FDA Catalysts and Solid Support: $SINT and $MYNZ$SINT rallies on FDA's green light for its innovative cancer drug, marking a new milestone in oncology solutions. Contrastingly, $MYNZ hovers near strong support, presenting a possible setup for patient traders. Biotech volatility is alive—manage risk wisely!